About Project

Nine africans partners are involved in this project such are Benin, Cameroon, Democratic Republic of Congo,  Ethiopia, Guinea, Mali, Nigeria, Rwanda and Senegal.

 

In some African partners (Benin and Rwanda) with advanced molecular laboratories,  the ‘Deeplex’ assay, a novel multiplex deep sequencing-based drug resistance diagnostic platform that simultaneously provides sequence information of genes that confer resistance to severals key anti-TB drugs has been implemented.

photo.jpg
DSC_0030_edited.jpg

Welcome On Diama Project

(Diagnosis of Multidrug resistant tuberculosis in Africa) website

The DIAMA (DIAgnostics for Multidrug resistant tuberculosis in Africa) study aims to address current gaps in the diagnosis and management of patients with Multi-Drug-Resistant (MDR) tuberculosis (TB).

Who We are?

A network of West, Central, East African as well as European instititions

Our Mission

To evaluate and implement rapid and accurate molecular tests for the management of drug resistant tuberculosis to replace the current dependency on culture.

Our Vision

To live in a world where drug resistant tuberculosis is managed without culture

Latest News & Events

Subscribe To Our Newsletter

For The Latest Updates, News and Events

Thanks for Subscribing!

Our Project Highlights

2018-06-22 16.38.28
PhotoGrid_1499944519285_edited
2018-06-22 16.41.41
PhotoGrid_1499944519285_edited
Image1
2016-11-23 14.54.58
DSC_0030
19042012-SAM_1993
2016-11-23 15.09.34
2016-11-23 11.02.27
DSC_0029
DSC_0042
1/2